Assessment of Enhanced Recovery After Surgery Implementation at Pediatric Surgery Practices in Mainland China

ERAS Clinical Trial

Official title:

Assessment of Enhanced Recovery After Surgery Implementation at Pediatric Surgery Practices in Mainland China: Based on a Survey of Performing Congenital Biliary Dilatation Operations

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05593861
• Other study ID #: NanjingCH13170
• Status: Completed
• Start date: July 1, 2021
• Est. completion date: July 21, 2022

Study information

• Verified date: October 2022
• Source: Nanjing Children's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Enhanced recovery after surgery (ERAS) is a new mode to optimize perioperative management, the core of which is to reduce perioperative physiological and psychological trauma and stress damage, and accelerate postoperative rehabilitation. ERAS has been gradually introduced in pediatric surgery in recent years, however, there are limited reports on its overall implementation. We aimed to determine the popularity of ERAS among pediatric populations in mainland China.

Description:

The application of ERAS in children with congenital biliary dilatation (CBD) was investigated. A total of 31 province-level administrative regions in mainland China were involved and each of them had at least one participating center. A questionnaire was designed to assess the baseline adherence of 17 recovery elements and chief pediatric surgeons at each center were invited to complete.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: July 21, 2022
• Est. primary completion date: July 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• chief pediatric surgeons at each center

Exclusion Criteria:

• Incomplete questionnaire

Related Conditions & MeSH terms

• ERAS

Locations

Country	Name	City	State
China	NJMU	Nanjing	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
Weibing Tang

Country where clinical trial is conducted

China, 

References & Publications (1)

Vacek J, Davis T, Many BT, Close S, Blake S, Hu YY, Holl JL, Johnson J, Strople J, Raval MV. A baseline assessment of enhanced recovery protocol implementation at pediatric surgery practices performing inflammatory bowel disease operations. J Pediatr Surg. 2020 Oct;55(10):1996-2006. doi: 10.1016/j.jpedsurg.2020.06.021. Epub 2020 Jun 27. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Barriers to implementation	Barriers to implementation	immediately after all the questionnaires are collected
Other	Outcomes of concern	Outcomes of concern	immediately after all the questionnaires are collected
Primary	Element adherence	Adherence to an element was determined if the frequency of practice reached specific thresholds as defined.	immediately after all the questionnaires are collected
Secondary	Factors associated with baseline ERAS utilization	Factors associated with baseline ERAS utilization	immediately after all the questionnaires are collected